Science

Next-generation imaging for evaluation in patients with prostate cancer after biochemical recurrence

Xavier Maldonado

Jan 23, 2025, 15:31

Next-generation imaging for evaluation in patients with prostate cancer after biochemical recurrence

Puigvert Foundation Barcelona shared an article by Xavier Maldonado, et al on X:

“Today in PiS Controversies in the use of next-generation imaging for evaluation and treatment decision-making in patients with prostate cancer after biochemical recurrence: views from a Spanish expert panel.“

Controversies in the use of next-generation imaging for evaluation and treatment decision-making in patients with prostate cancer after biochemical recurrence: views from a Spanish expert panel.

Authors: Xavier Maldonado, et al.

Biochemical Recurrence cancer fight against cancer Fundació Puigvert Barcelona Global fight against cancer OncoDaily Oncology PIs prostate cancer Xavier Maldonado

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

New Paper Alert Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience

Highlights from TTLC2025

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding